Seizure Management

Introduction to Seizure Prophylaxis

Seizure prophylaxis in patients with CNS disease or history of seizures is recommended with a lower dose of 10 mg/kg up to 500 mg per dose every 12 hours 1

The American Academy of Neurology recommends considering levetiracetam or lamotrigine for patients experiencing adverse effects from valproate, due to their more favorable side effect profiles 2
Levetiracetam may be initiated at 500mg twice daily with a side effect profile that includes irritability but less sedation than valproate 2
The typical adult dose for levetiracetam is 1000 mg every 12 hours, as recommended by the American Academy of Emergency Medicine (high level of evidence) 3
Lamotrigine requires slow titration over several weeks to avoid serious skin reactions, starting at 25mg daily for 2 weeks, then gradually increasing 2
Topiramate can be effective for multiple seizure types, but caution is advised due to potential cognitive slowing and association with hyperammonemic encephalopathy when combined with valproate (American Epilepsy Society) 4
Carbamazepine may be considered for partial seizures, though it is less effective for absence seizures (American Academy of Pediatrics) 5
Zonisamide may be an alternative when topiramate has excessive side effects (American Academy of Neurology) 4

Abrupt discontinuation of antiepileptic drugs can precipitate status epilepticus (American Academy of Neurology) 2
The safest approach to switch from levetiracetam to lamotrigine is through gradual cross-titration over several weeks (American Academy of Neurology) 6
Initial phase: Start lamotrigine at 25mg daily for 2 weeks while continuing full dose of levetiracetam (500mg twice daily) (American Academy of Neurology) 6
Titration phase: Increase lamotrigine to 50mg daily for 2 weeks, then to 100mg daily (50mg twice daily) for 2 weeks, while maintaining full levetiracetam dose (high level of evidence) 6
Cross-taper phase: Increase lamotrigine to 150mg daily (75mg twice daily) and begin reducing levetiracetam to 500mg daily, with further adjustments as needed 6

During cross-titration, monitor for seizure recurrence, improvement in somnolence, fatigue, speech function, and watch for skin rashes with lamotrigine (American Academy of Neurology) 2
The International League Against Epilepsy advises tracking seizure activity using a seizure diary and considering checking ammonia levels if encephalopathy symptoms persist 4
Patients should immediately report any skin changes, as this could indicate a serious adverse reaction to lamotrigine (FDA, high level of evidence) 7
Monitor for irritability, mood changes, or psychiatric symptoms with either medication (low level of evidence) 7
Valproate can cause somnolence, fatigue, and encephalopathy symptoms, which can significantly impair quality of life 2
Levetiracetam has common adverse effects including somnolence (10.5-15.2%), asthenia, dizziness, and irritability (American Academy of Emergency Medicine, high level of evidence) 3
Approximately 89% of patients do not report significant adverse effects after levetiracetam loading dose, with behavioral adverse effects occurring in approximately 12-15% of patients (moderate level of evidence) 3

Women of childbearing potential should not be prescribed valproate due to its teratogenicity risk (American College of Obstetricians and Gynecologists) 8
Patients with renal impairment require levetiracetam dose adjustments based on creatinine clearance:

Creatinine Clearance	Recommended Dose
50-80 ml/min	500-1000 mg every 12 hours
<50 ml/min	250-500 mg every 12 hours

Patients at higher risk for behavioral side effects (history of psychiatric disorders or intellectual disability) may require slower titration and closer monitoring (low level of evidence) 9, 10
For patients with risk of paradoxical effects, start with lower doses and slower titration (American Academy of Neurology, moderate level of evidence) 11
For children, doses above 20 mg/kg/day should be introduced with caution (American Academy of Pediatrics, high level of evidence) 11
Monitor for weight changes with alternative medications like topiramate, which may cause weight loss (National Institute of Neurological Disorders and Stroke) 4

For status epilepticus, a loading dose of 30 mg/kg IV levetiracetam (max 2500 mg) is recommended, administered at 5 mg/kg per minute (American Academy of Emergency Medicine, high level of evidence) 3, 1
Levetiracetam has an efficacy of 67-73% in controlling refractory status epilepticus (American Academy of Emergency Medicine, high level of evidence) 3, 1
A dose of 1500 mg levetiracetam has been found to resolve status epilepticus in 7 out of 9 patients (78%) within 30 minutes (moderate level of evidence) 3